CAS 189996-60-9

Furo[3,4-d]-1,3-dioxol-4-ol, tetrahydro-2,2-dimethyl-, (3aR,6aR)-

Description:

Furo[3,4-d]-1,3-dioxol-4-ol, tetrahydro-2,2-dimethyl-, (3aR,6aR)-, with CAS number 189996-60-9, is a chemical compound characterized by its unique bicyclic structure that incorporates a furan ring fused to a dioxole moiety. This compound features a tetrahydrofuran-like framework, which contributes to its stability and reactivity. The presence of hydroxyl (-OH) groups indicates potential for hydrogen bonding, influencing its solubility and interaction with other molecules. The stereochemistry, denoted by (3aR,6aR), suggests specific spatial arrangements of its substituents, which can significantly affect its biological activity and chemical reactivity. Such compounds often exhibit interesting pharmacological properties, making them of interest in medicinal chemistry. Additionally, the dimethyl substitution enhances steric hindrance, potentially impacting its conformational flexibility and interactions with biological targets. Overall, this compound exemplifies the complexity and diversity of organic molecules, particularly those derived from natural products or designed for specific applications in pharmaceuticals or materials science.

Formula: C₇H₁₂O₄

2,3-O-Isopropylidene-D-erythrofuranose

CAS: 189996-60-9

2,3-O-Isopropylidene-D-erythrofuranose

Purity: >98%

Molecular weight: 144.17g/mol

Ref: 54-BICL4118

2,3-O-Isopropylidene-D-erythrofuranose

CAS: 189996-60-9

Ref: 7W-GC8613

2,3-O-Isopropylidene-D-erythrofuranose

CAS: 189996-60-9

2,3-O-Isopropylidene-D-erythrofuranose is a synthetic anticancer agent that inhibits the synthesis of proteins. It binds to the sulfhydryl group of cysteine, which is an amino acid that is essential for protein synthesis. 2,3-O-Isopropylidene-D-erythrofuranose has been shown to be potent in inhibiting cancer cells and has been used in the treatment of leukemia and other cancers. This drug can also be used as a means of treating lysosomal storage diseases such as Gaucher's disease. Its anticancer activity may be due to its ability to inhibit glutamate dehydrogenase and glutathione reductase enzymes, which are required for the synthesis of glutathione, an important antioxidant enzyme.
2,3-O-Isopropylidene-D-erythrofuranose has been synthesised from l -tartaric

Formula: C₇H₁₂O₄

Purity: Min. 95%

Molecular weight: 160.17 g/mol

Ref: 3D-MI10311